Abstract
In directed evolution, enzyme activity is improved in successive generations of laboratory evolution, which can be described by a simple stepwise climb toward a peak in the fitness landscape. In a naive model of evolution, it can be assumed that each enzyme variant along this path is in a single, well‐defined state that differs slightly from the previous one. We analyzed the structural changes in mutants of the β‐lactamase BlaC from Mycobacterium tuberculosis obtained via directed evolution for increased ceftazidime hydrolysis activity. Crystal structures of three successive mutants only show an increase in the dynamics of a loop that lines the active site (Ω‐loop), enabling better access of the large substrate. However, NMR spectra of wild type and nine mutants of different branches of the directed evolution experiment show a much more diverse and complex picture of the conformational effects. Many mutants show micro‐millisecond dynamics for certain regions and most show peak doubling, indicative of two or more conformations being populated. Thus, the straightforward climb to increased ceftazidime activity in the fitness landscape masks a complex trajectory in the conformational landscape, emphasizing the complex and epistatic interplay that single mutations can have on the structure and dynamics of enzymes.
Keywords: beta‐lactamase, NMR, protein dynamics, protein evolution, x‐ray crystallography
1. INTRODUCTION
Directed evolution allows for rapid enhancement of enzyme activity on poor substrates (Campbell et al., 2018; Martínez & Schwaneberg, 2013; Nirantar, 2021; Vidal et al., 2023). Selection for enhanced activity can result in a stepwise, progressive climb toward a fitness peak in a limited number of generations. The underlying structural changes accompanying the change in activity can in some cases be described by a change in the population of two states, one inactive and the other active (Otten et al., 2020; St‐Jacques et al., 2023). Such a binary system may, however, not be a general situation because the effect of mutations in proteins depends on the background of all residues (epistasis) and can have unpredictable effects. Generally, protein folds are resistant to the effects of mutations and overall, the structures of the enzymes of successive generations of laboratory evolution may change little. However, subtle changes in atomic positions can already affect the atomic interactions and hydrogen bond (H‐bond) network and, thus, the activity of an enzyme (Campbell et al., 2016; Campitelli et al., 2020). Also, changes in the dynamics can strongly influence catalytic properties (Bhabha et al., 2013; Fisette et al., 2012; Fraser et al., 2009; Gobeil et al., 2014; Jackson et al., 2009; Maria‐Solano et al., 2018; Rossi et al., 2022). Though progress has been made using AI (Casadevall et al., 2023; Wayment‐Steele et al., 2024), changes in enzyme conformation remain difficult to predict and may be more complex than a progressive change in phenotype suggests. We investigated the structural adaptations and conformational dynamics that underly functional changes by directed evolution of the β‐lactamase BlaC. BlaC is a class A serine β‐lactamase found in Mycobacterium tuberculosis (Wang et al., 2006). The enzymes in this class utilize an active site serine (Ser70) to perform a nucleophilic attack on β‐lactam rings, forming a covalent acyl‐enzyme intermediate that is subsequently hydrolyzed (Fisher & Mobashery, 2009; Strynadka et al., 1992). BlaC can efficiently hydrolyze penicillin antibiotics but has low activity against later‐generation oxyimino‐cephalosporins, such as ceftazidime, due to their bulky C7β aminothiazole‐oxyimino side chain (Sun et al., 2023; Wang et al., 2006). Recently, we reported that ceftazidime hydrolysis is enhanced by a single mutation, P167S (Ambler numbering) (Ambler et al., 1991) in BlaC, in line with what was reported for other β‐lactamases (Papp‐Wallace et al., 2017; Poirel et al., 2001; Stojanoski et al., 2015; Sun et al., 2023). The mutation changes a cis peptide bond to trans, causing the opening of the Ω‐loop (residue 164–179) and enlarging the active site. However, although enhanced, the catalytic efficiency remains low compared to that of WT BlaC for other substrates, such as ampicillin and nitrocefin (Sun et al., 2023). Laboratory evolution of other β‐lactamases was used to enhance the catalytic efficiency against ceftazidime, and the regions affected by mutations included the Ω‐loop (Alsenani et al., 2022; Bae et al., 2006; Delmas et al., 2006; Hobson et al., 2022; Nijhuis et al., 2015; Papp‐Wallace et al., 2017; Poirel et al., 2001), the gatekeeper loop (residue 103–106) (Feiler et al., 2013), and the B3 β‐strand (residue 233–246) (Brown et al., 2020; Delmas et al., 2006; Kemp et al., 2021). A recent study on β‐lactamase OXA‐48 also improved the ceftazidime resistance through rounds of directed evolution, elucidating the molecular mechanisms underlying epistasis (Fröhlich et al., 2024).
In the current study, BlaC was evolved to enhance ceftazidime activity to explore the changes in conformations and dynamics, which were analyzed with crystallography and NMR spectroscopy. Crystal structures show increasing dynamics in the Ω‐loop along the evolutionary trajectory. The overall structure of the remaining part of the protein displayed hardly any differences. The NMR analysis showed a more intricate picture and revealed a surprising complexity of conformational states, exhibiting enhancement in μs–ms dynamics in several regions, as well as the population of multiple states for global or local parts of the protein, with patterns that changed in each successive next generation. It is concluded that during the directed evolution, many different states are visited in the conformational landscape, indicating that the destabilization of the Ω‐loop enabled access to a wide range of new conformations.
2. RESULTS
2.1. BlaC can readily be evolved to high ceftazidime activity
In a screen for BlaC mutants with improved ceftazidime resistance in an Escherichia coli expression system at three temperatures (23, 30, and 37°C), the BlaC variant P167S/D240G (PD) was found at 30°C, exhibiting a 16‐fold increased resistance for ceftazidime as compared to the wild‐type (WT). Grown at 23 and 37°C, the resistance of this PD variant was eightfold greater than that of WT (Table 1). To test how resistance would further evolve and with which trade‐offs (Noda‐Garcia & Tawfik, 2020), directed evolution was performed using the blaC gene of the PD variant as the template. It was decided to perform the selection at two temperatures to establish whether accessible mutational pathways would differ. A library of random mutants was generated using error‐prone PCR and three successive rounds were performed (generations G1–G3) at 23 or 37°C, using increasing ceftazidime concentrations, as indicated in Figure 1a. In every screen, 106 to 108 clones were sampled. In the selection performed at 23°C, G1 yielded mutant P167S/D240G/T208I/T216A (PDTT), in G2 mutation I105F was acquired (PDTTI), and in G3, D176G was added (PDTTID). At 37°C, two variants were found that were further evolved, yielding P167S/D240G/D172A/S104G/H184R (PDDSH) and P167S/D240G/I105F/H184R (PDIH) in G3, respectively (Figure 1b). The PDIH variant evolved in G2 but was sufficiently resistant to grow under the conditions of G3. After the third generation, no further improvements were obtained with this method. The minimum inhibitory concentration (MIC) was determined using drop assays of OD600 0.3–0.0003 on agar plates containing a range of antibiotic concentrations. This approach is more subtle than the standard power‐of‐two MIC determination (Figures S1–S3) (van Alen et al., 2023). The mutants selected at 37°C display more than 15‐fold increased resistance compared to PD and over 120‐fold compared to WT (Table 1).
TABLE 1.
Minimal concentrations of ceftazidime at which growth of E. coli producing BlaC wild‐type and mutants is not observed (MIC), determined with a droplet test. The estimated error is 5 μg/mL, based on the differences in growth between plates with increasing amounts of ceftazidime (Figures S1–S3).
| Mutations | G | Selection | μg/mL | ||
|---|---|---|---|---|---|
| Temp. (°C) | 23°C | 30°C | 37°C | ||
| WT | <0.5 | <0.5 | 0.5 | ||
| P167S/D240G (PD) | 0 | 30 | 4 | 8 | 4 |
| P167S/D240G/I105F (PDI) | 1 | 37 | 8 | 30 | 16 |
| P167S/D240G/I105F/H184R (PDIH) | 3 | 37 | 15 | 63 | |
| P167S/D240G/T208I/T216A (PDTT) | 1 | 23 | 20 | 55 | |
| P167S/D240G/T208I/T216A/I105F (PDTTI) | 2 | 23 | 35 | 60 | |
| P167S/D240G/T208I/T216A/I105F/D176G (PDTTID) | 3 | 23 | 63 | 63 | |
| P167S/D240G/D172A (PDD) | 1 | 37 | 10 | 35 | |
| P167S/D240G/D172A/S104G (PDDS) | 2 | 37 | 10 | 45 | |
| P167S/D240G/D172A/S104G/H184R (PDDSH) | 3 | 37 | 15 | 63 | |
Abbreviation: G, generation.
FIGURE 1.

Schematic representation of the directed evolution trajectory and obtained variants. (a) Amino acid mutations obtained in successive generations are shown and the ceftazidime concentration and the temperatures used for selection are indicated. (b) The locations of the mutations (Cα atoms) acquired during selection at 23°C (T216A, T208I, D176G, green spheres, I105F, yellow sphere) and 37°C (D172A, S104G, and H184R, blue spheres, I105F, yellow) are shown on the WT BlaC structure (PDB: 2GDN; Wang et al., 2006) in tube representation and the thickness of the tubes correlates with B‐factors. The catalytic residue Ser70 is shown in sticks, the mutations in the template (P167S and D240G) are indicated as pale blue spheres, and the Ω‐loop is colored purple.
2.2. Protein stability is increased in successive generations
To characterize the BlaC variants further, the enzymes were overproduced in E. coli and purified. The yield of soluble protein of variant PD was reduced relative to that of WT BlaC. For the variants from the successive generations of direct evolution, the level of soluble protein increased (Figure S4a). The thermostability of all purified variants was determined in a Trp fluorescence assay. The parent variant for evolution, PD, showed a melting temperature (T m) of 52.8°C, a decrease of 9.2°C compared to WT BlaC (62°C, Figure S4b and Table 2) (van Alen et al., 2023). Each mutant selected at 37°C displayed better stability than its parent. At 23°C, a further decrease in T m was seen in G1 (−11.3°C), followed by increasing values in the next two generations. Thus, thermostability and solubility assays show the same trend, suggesting that the stabilizing effects of the mutations contribute to the better performance of the variants in later generations (Nearmnala et al., 2021; Nirantar, 2021).
TABLE 2.
Melting temperatures for BlaC variants.
| BlaC variant | G | Selection temp. (°C) | T m (°C) a | ΔT m (SD) (mut‐WT) (°C) | ΔT m (SD) (mut‐templ.) (°C) |
|---|---|---|---|---|---|
| WT | 62.0 | — | |||
| P167S/D240G (template) | 0 | 30 | 52.8 | −9.2 | — |
| P167S/D240G/T216A/T208A (PDTT) | 1 | 23 | 50.7 | −11.3 | −2.1 |
| P167S/D240G/T216A/T208A/I105F (PDTTI) | 2 | 23 | 52.6 | −9.4 | −0.2 |
| P167S/D240G/T216A/T208A/I105F/D176G (PDTTID) | 3 | 23 | 53.8 | −8.2 | 1.0 |
| P167S/D240G/D176G (PDD) | 1 | 37 | 54.0 | −8.0 | 1.2 |
| P167S/D240G/D176G/S104G (PDDS) | 2 | 37 | 55.3 | −6.7 | 2.5 |
| P167S/D240G/D176G/S104G/H184R (PDDSH) | 3 | 37 | 57.5 | −4.5 | 4.7 |
| P167S/D240G/I105F (PDI) | 1 | 37 | 55.0 | −7.0 | 2.2 |
| P167S/D240G/I105F/H184R (PDIH) | 3 | 37 | 56.8 | −5.2 | 4.0 |
Abbreviation: G, generation.
The estimated error from triplet experiments in T m is 0.1°C–0.2°C.
2.3. A trade‐off in ceftazidime and nitrocefin activities
To evaluate the β‐lactam resistance profile of the evolved BlaC mutants, kinetic parameters were determined. Increased ceftazidime activity could be accompanied by trade‐offs, therefore, both ceftazidime and nitrocefin (Structures are shown in Figure S5) hydrolysis rates were measured. It is noted that nitrocefin is a chromogenic substrate and not antibiotic used in the clinic. However, it is suitable to detect trade‐off effects. Nitrocefin hydrolysis exhibits classical (apparent) (Sun et al., 2023) Michaelis–Menten kinetics (Figure S6a). The catalytic efficiencies () decrease up to 150‐fold for the variants, compared to WT BlaC (Table S1), indicating that the directed evolution for enhanced ceftazidime resistance compromised nitrocefin activity. The reaction kinetics for the hydrolysis of ceftazidime are more complex, as was also observed for BlaC P167S (Sun et al., 2023). In the first 5 min, the product formation curve exhibits biphasic kinetics for BlaC variants PDD and PDDSH, with an initial fast phase, followed by a slower, linear phase (Figure 2a). The BlaC variants PDTT and PDTTID variants hydrolyzed ceftazidime so rapidly that two phases could not be distinguished. Thus, at least in some of the variants, classical Michaelis–Menten kinetics are not applicable, and therefore, to compare the relative activities under these specific conditions, we defined a catalytic turnover number as the initial rate of product (P) formation in this assay, measured from the initial slope of the product curve, per enzyme (E) molecule, (s−1). The third‐generation variants showed a 4‐ to 35‐fold increase in catalytic turnover compared to the parent mutant PD, and a 55‐ to 255‐fold increase compared to the WT at 25°C (Figure 2b and Table S2). The catalytic turnover numbers increase monotonously with temperature to 35°C, equally for the mutants selected at 23 and 37°C (Figures 2b and Figure S6b), indicating that the former ones do not suffer from short‐term stability problems at this temperature, in line with the in‐cell results (Figure S1).
FIGURE 2.

Enzyme activities. (a) Product formation curves of ceftazidime hydrolysis at 25°C for G1 and G3 variants. (b) Temperature dependence of the turnover numbers for ceftazidime hydrolysis. All experiments were performed with 1 μM enzyme in 100 mM sodium phosphate buffer, pH 6.5. Error bars represent the standard deviation of the mean of duplicate measurements.
2.4. Directed evolution is accompanied by a complex variety of conformational states
The ceftazidime fitness and protein stability increases that are observed during the successive steps of selection indicate a straightforward uphill walk in the evolutionary landscape toward a new fitness peak. To determine the accompanying conformational changes, the mutants were characterized by crystallography and NMR spectroscopy. The Ω‐loop of BlaC P167S was reported to be in two conformations, a semi‐closed and an open state (Sun et al., 2023). The crystal structures of BlaC variants PD, PDDS, and PDDSH were solved at 1.3, 1.6, and 1.4 Å resolution, respectively. While the refinement statistics for the PD and PDDS structures are within the expected values for the resolution (Rfree of 18 and 17, respectively, Table S3), the PDDSH dataset suffers from translational non‐crystallographic symmetry, resulting in a higher Rfree value of 25. Between these mutants, significant differences are observed in the Ω‐loop (Figure 3). For BlaC PD, the Ω‐loop exhibits a large conformational change compared to WT, resulting in a significant expansion of the active site cavity (Figure 3a, yellow), in line with the changes observed for BlaC P167S (green), which were attributed to the cis‐to‐trans change in the peptide bond between residues 166 and 167 (Sun et al., 2023). In PDDS (blue), the loss of the negatively charged carboxyl group of Asp172 (to Ala) causes disruption of the low‐barrier H‐bond of D179‐D172, which was shown before to stabilize the Ω‐loop in WT BlaC (Sun et al., 2024). As a consequence, the chain between residues 167 and 172 is only partially ordered, indicating mobility in this region of the Ω‐loop (Figure 3b). In the BlaC variant PDDSH (purple in Figure 3a), the Ω‐loop residues 165–172 are disordered, indicating still more conformational flexibility (Figure 3b). In this variant, the peptide bond between Gly104 and Ile105 is flipped, and the gatekeeper loop moves 2.5 Å compared to the PD and PDDS variants, enlarging the active site (Figure 3c). Thus, during this evolutionary trajectory, disorder in the Ω‐loop increases, whereas the rest of the structure remained similar.
FIGURE 3.

Crystal structures of BlaC P167S/D240G (PD, PDB ID: 9HIT), P167S/D240G/D172A/S104G (PDDS, PDB ID: 9HCK), and P167S/D240G/D172A/S104G/H184R (PDDSH, PDB ID: 9HJ2). (a) An overlay is shown of the crystal structures of Ω‐loops of P167S (green, PDB 8OEI [Sun et al., 2023], two conformations), PD (yellow), PDDS (blue), PDDSH (purple, two conformations) and WT (gray, PDB 2GDN; Wang et al., 2006). Missing density for the backbone is indicated with dashed coils. (b) Electron density of Ω‐loops of PD, PDDS, and PDDSH structures. The well‐ordered Ω‐loop of PD (left) (residues 165 to 175) is indicated by 2|Fo‐Fc| maps (blue), contoured at 1.0 σ. The structures of mutant PDDS (middle) and PDDSH (right) show weak or absent density for the Ω‐loop. The electron density poor region of Ω‐loop in the PDDSH was modeled using the Ω‐loop of the WT. (c) The positions of Arg103, Ser104/Gly104, Ile105, and Ser106 in the gatekeeper loop are shown. The overlay of PD (yellow) and WT (gray) is shown in the left panel. The middle and right panels show the overlays of PD (yellow) with PDDS (blue) and PDDSH (purple), respectively.
Crystallization tends to select a single conformation from multiple states in solution, and only the absence of electron density (disorder) is an indication of conformational diversity. NMR spectroscopy is sensitive to conformational exchange, and the effects on the spectrum depend on the rate of exchange (Figure 4). The 1H–15N TROSY‐HSQC spectra were assigned for all mutants, using HNCA experiments and the available assignments for WT BlaC (Elings et al., 2017). Chemical shift perturbations were observed in large parts of the protein as a consequence of the mutations (Figure S7). The signals of the amides of the Ω‐loop are missing, indicating that they sample different conformations that exchange on the intermediate‐fast timescale (100 s−1). Furthermore, peak doubling occurs in many of the mutants. The appearance of two peaks for one amide group indicates that it occurs in two states that exchange slowly (<<50 s−1). We analyzed the doubling effects by comparing, for each successive mutant with its predecessor, whether for an amide resonance doubling remained present and whether the relative orientation of the peaks remained the same. If the resonance of an amide is still doubled but at least one of the two peaks is in a different position, the amide experiences a new state (see examples in Figure 5). In Figure 6, the residues with missing signals are indicated in red cartoon representation, and amide nitrogen atoms that show peak doubling are plotted as spheres on the structure of WT BlaC. State changes for each nitrogen atom are indicated in different colors. A remarkably complex behavior of peak doubling and intermediate exchange is observed. It is clear that in most mutants a large number of amides experience more than a single state. Furthermore, new pairs of conformations are accessed in each mutant. In some cases, a mutation leads to peak doubling in large regions, suggesting conformational changes that involve a large part of the protein (for example, P167S and S104G), whereas others cause new local conformations to be populated (D240G and I105F). Some mutations stabilize a single conformation, largely eliminating the peak doubling (D172A), and others stabilize one part of the protein and introduce new peak doubling and, consequently, new conformational states, in other regions (H184R). The effect of a mutation also depends on its background (epistasis), as is clear for mutation H184R, which occurred in two branches of the directed evolution trajectory.
FIGURE 4.

Schematic illustration of the effects on the NMR peaks (shown as contours) due to the presence of multiple conformations. For conformations in slow exchange, peak doubling is observed; for intermediate exchange, large line broadening occurs, and signals become undetectable.
FIGURE 5.

Details of 1H‐15N TROSY‐HSQC spectra showing resonances for residues of BlaC P167S/D240G (magenta) and evolved BlaC mutants (navy). The green and blue backgrounds represent the variants that were selected at 23°C and 37°C, respectively. The open and closed states refer to those described for BlaC P167S (Sun et al., 2023).
FIGURE 6.

Conformational variations in BlaC upon introduction of mutations based on the NMR results. The nitrogen atoms of amide groups that display peak doubling are shown as spheres. Small spheres in the Ω‐loop indicate that the amides exist in two states, one of which is broadened beyond detection (as inferred from halved intensities) (Sun et al., 2023). Residues with missing amide signals are indicated in red cartoon. In WT BlaC, no peak doubling is observed. The mutant P167S was reported before to show amides with double peaks, indicated in magenta (Sun et al., 2023). In BlaC PD part of the peak doubling pattern is the same as in P167S and part has changed (pale green). Introduction of additional mutations found in the directed evolution branches changes the peak doubling and broadening patterns in each case. The mutation sites are shown in cyan.
3. DISCUSSION
Selection for gain‐of‐function of an enzyme via directed evolution is often accompanied by destabilization (Bloom & Arnold, 2009; Fasan et al., 2007; Fasan et al., 2008; Socha & Tokuriki, 2013; Stimple et al., 2020; Tokuriki et al., 2008; Tokuriki & Tawfik, 2009). Stability loss is also clearly observed when selecting for enhanced ceftazidime activity in BlaC, as indicated by a decrease in the melting temperature of more than 9°C for the PD mutant and more than 11°C for the PDTT mutant. In the next generations, stability was regained while, simultaneously, activity was further enhanced. The T m values were measured for purified protein in vitro, reflecting intrinsic stability under defined conditions and cannot be translated directly to stability in the complex environment of the bacterial periplasm. However, we have noted before a clear correlation between an increase in β‐lactamase T m and protein level in the periplasm (Radojković et al., 2025).
Directed evolution was performed by selecting for increased ceftazidime resistance at both 23°C and 37°C, to investigate how temperature shapes adaptive pathways, stability, and function in BlaC. MIC determination was conducted at the corresponding selection temperatures to enable correlation between the selection environment and resistance phenotype. Variants selected at 37°C display increased antibiotic resistance but did not regain WT‐like stability, suggesting that enhanced activity can be achieved despite stabilization loss. In contrast, variants selected at 23°C initially underwent significant stability loss but partially regained thermal stability through compensatory mutations over successive generations. These findings align with previous reports indicating that elevated temperatures intensify selection against protein instability and restrict mutational space, whereas lower temperatures permit exploration of alternative or more destabilizing adaptive pathways (Berezovsky & Shakhnovich, 2005; Tokuriki et al., 2007; Tokuriki & Tawfik, 2009). Kinetic analyses were performed primarily at 25°C for comparability with the literature, with additional measurements in the range from 10°C to 35°C to assess the temperature dependence of catalysis. The temperature dependence profiles of the mutants selected at 23°C or 37°C (Figure 2) do not show clear differences.
It is well‐established that enhanced flexibility of the Ω‐loop of β‐lactamases can lead to higher ceftazidime activity, because opening of the active site facilitates access for this large substrate (Brown et al., 2020; Sun et al., 2023; Yi et al., 2016). Conformational changes in this loop also lead to displacement of the catalytic residue Glu166, which appears not to be required for ceftazidime hydrolysis (He et al., 2020; Sun et al., 2024; Tooke et al., 2023), contrary to what is the case for penicillins and first and second generation cephalosporins (Pemberton et al., 2020; Strynadka et al., 1992). The initial mutations found in the selection screens are located in or close to the Ω‐loop (P167S, D240G), and also in later rounds such mutations were found (D172A, D176G). Some have been described before to destabilize the loop (Ghiglione et al., 2018; Novais et al., 2010; Papp‐Wallace et al., 2017; Patel et al., 2015; Poirel et al., 2001; Stojanoski et al., 2015). Also, two mutations in the gatekeeper loop were found (S104G and I105F). As the name suggests, this loop covers part of the entry to the active site and lies over the Ω‐loop (Feiler et al., 2013), and these mutations further enhance the accessibility of the active site (Poirel et al., 2001; Radojković & Ubbink, 2024; Yi et al., 2012). Three mutations are found far away from the Ω‐loop (H184R, T208I, and T216A), two of which are also far from the active site. His184 and Thr208 both have a Cα‐Cα distance to the catalytic Ser70 between 16 and 17 Å. The intermediate exchange regime observed in the NMR spectra shows that the double mutation T208I/T216A leads to flexibility of the α‐helix and connecting loop in which these two residues are located, which suggests that it opens up the active site on the opposite side of the Ω‐loop. Mutation H184R occurred twice, in different branches of the directed evolution experiments and in both cases causes an increase in the melting temperature, suggesting, therefore, that this mutation is generally stabilizing. In another laboratory evolution experiment, our group identified the same mutation in a search for global stabilizing mutations (Radojković et al., 2025). An Arg at position 184 could potentially form salt bridges with Glu59 and Asp63 and a cation‐π interaction with Tyr48.
For one branch of the directed evolution experiment, we managed to obtain crystal structures of the successive mutants, PD, PDDS, and PDDSH, showing the opening and increasing disorder of the Ω‐loop in an otherwise defined protein structure, suggesting minor structural changes. Campbell et al. reported a similar series of crystal structures of enzymes along a directed evolution pathway and also found minimal changes in atomic positions, but significant differences in atomic interactions and H‐bond networks. Furthermore, they observed increased dynamics in certain loops and loss of unproductive motions (Campbell et al., 2016). The NMR spectra paint a complex picture, showing dynamics on μs–ms timescales in several regions around the active site (red cartoons in Figure 6), as well as a remarkable variety of peak doubling patterns, indicating that the directed evolution strongly affected the internal dynamics of BlaC. Observation of dynamics on several timescales of evolved enzymes was also reported by Otten et al. for a system in which dynamics were essential for catalysis (Otten et al., 2018), and González et al. showed how μs–ms dynamics can be optimized in directed evolution (González et al., 2016). In the P167S and PD variants, peak doubling is observed for many amides, indicating that a large part of the protein populates two states. Introduction of every next mutation changes the distribution of states, introduces new states in parts of the protein and, in some cases, leads to a single state for most of the amides. This diversity of states seems uncorrelated with the stability. To illustrate the results, a schematic is shown in Figure 7 in which black and gray lines schematically represent conformational states in various regions of the protein with coherent peak doubling behavior (indicated with colored ovals). The vertical position of the mutant represents the instability, using the melting temperature as a proxy, and the red bars indicate the relative turnover number of ceftazidime (Table S2). WT BlaC is stable and in a single, well‐defined conformation. Upon disruption of the Ω‐loop, the protein enters a region in the conformational space in which many conformations are easily accessible and single mutations readily lead to the population of new states. The most active variants (G3) have not regained a single, well‐defined state.
FIGURE 7.

Schematic representation of conformational states. For each BlaC variant conformational states are indicated as black and gray curves. In protein regions in which peak doubling is observed, the black and gray curves differ, highlighted by the colored ovals. The light pink, purple, and blue ovals schematically indicate the presence of distinct states, as evidenced by regions exhibiting coherent peak doubling of amides. The higher the position in the graph, the lower the melting point of the variant, indicating its instability. Note the variety of conformational states among the variants. The red bars represent the relative catalytic turnover number (Table S2) for ceftazidime hydrolysis. The vertical dashed lines separate the different branches of the directed evolution tree.
The NMR spectra are sensitive to the presence of different states but give no information about what they look like. Peak doubling mostly results in resonances close together in the spectrum, suggesting that the conformational changes are not large, though the slow exchange regime indicates that the energy barriers between them are sizable. The conformational changes may be too small to be detected by x‐ray crystallography, or the crystallization process may favor one of them. Even if the conformational states differ only slightly, the large variation is striking, given that WT BlaC is in a single conformational state. Our results indicate that additional states are readily accessed upon the introduction of a few mutations, yet in NMR spectra of native, folded proteins, extensive peak doubling is exceptional. That observation suggests that the natural selection pressure for a single, well‐defined state must be strong; otherwise, multiple states would be observed also for native proteins.
4. CONCLUSIONS
Directed evolution is an effective method to enhance specific functions of enzymes. Selection is based on a single parameter; an increase in activity and a gradual gain in successive generations is usually observed. This process is often described as a climb to the top of a fitness landscape. As native enzymes generally have a well‐defined structure with a single conformation, naively, it can be assumed that each enzyme variant along the evolutionary trajectory is also in a single conformation; in other words, that the conformation landscape resembles the fitness landscape. Alternatively, binary models are used, in which a gradual population change occurs from a defined inactive conformation to an active one. This picture is too simple for the case reported here. The conformational landscape is much more complex, with multiple global or local conformational states being populated in the successive steps, without a clear relationship between stability and restriction of the conformational space. The optimized enzymes have not (yet) attained a single conformation. It will be of interest to determine whether such variety of conformations is observed also in the directed evolution of other enzymes as well as in natural evolution, for example, by using resurrected ancestral proteins.
5. MATERIALS AND METHODS
5.1. Construction of a random mutant library
The initial BlaC mutant library was constructed by carrying out error‐prone polymerase chain reactions (EP‐PCR) using the blaC gene as the template (Sun et al., 2023). The gene encodes an E. coli expression‐optimized blaC gene with a TAT signal sequence for translocation to the periplasm. Only the gene coding for the mature enzyme, not the signal sequence or the vector, was amplified and mutated. For the directed evolution, plasmids from clones selected from a preceding evolutionary round were subjected to EP‐PCR with a GeneMorph II Random Mutagenesis Kit. Initial denaturation was performed at 95°C for 2 min, followed by 30 cycles of denaturation at 95°C for 30 s, annealing at 60°C for 30 s, and extension at 72°C for 3 min. The DNA concentration of the libraries was normalized by estimating the PCR yield based on gel band intensity in comparison with that of the 1.1‐kb standard.
5.2. Selection on plates
The mutated blaC gene libraries were cloned behind the lac promoter in pUK21 through restriction and ligation using BglII and XhoI restriction sites. E. coli KA797 cells were transformed with the plasmid library and plated on lysogeny broth (LB) agar plates with kanamycin (50 μg/mL), isopropyl β‐d‐1‐thiogalactopyranoside (IPTG, 1 mM), and varying concentrations of ceftazidime (1, 10, 25, 40, and 60 μg/mL). The plates for the template were incubated at 23, 30, or 37°C for 3 days, 18 h, or 12 h, respectively. Approximately 5 × 105 clones were screened at each temperature, and three blaC clones were found on the plate incubated at 30°C. For the following directed evolution selection, plates were incubated at 23 or 37°C. Approximately 1 × 107 clones were screened at each temperature per selection round. Colonies were transferred to LB liquid cultures and incubated overnight at 37°C and 250 rpm. Plasmids were isolated and transformed into fresh E. coli KA797 cells to confirm that resistance was the result of mutations in the blaC gene and not due to changes in the host cell. The mutations were identified by DNA sequencing.
5.3. Antimicrobial susceptibility testing
Antibiotic resistance was tested in the E. coli cells carrying pUK21‐blaC plasmids with the gene behind the lac promoter. Ten‐microliter drops of E. coli cultures with optical densities (OD600) of 0.3, 0.03, 0.003, and 0.0003 were applied on the LB plates containing 50 μg/mL kanamycin (to maintain the plasmid), 1 mM IPTG, and varying concentrations of ceftazidime (0.5–65 μg/mL). The MIC was determined using a drop assay. The plates were incubated at 23 or 37°C until growth was visible and imaged using a Gel Doc XR+ (Bio‐Rad) and ImageLab version 6.0.1 (Bio‐Rad).
5.4. BlaC production
The genes for all BlaC mutants were cloned into pET28a + plasmids downstream of an N‐terminal His‐tag with T7 promoter and a TEV cleavage site by using the Gibson assembly method. The proteins were produced and purified according to previously described protocols (Elings et al., 2017). Pure protein was stored at −80°C in 100 mM sodium phosphate (pH 6.5). For determination of the amount of soluble protein, the OD600 of the overnight culture was adjusted to 1, and 500 μL was centrifuged and resuspended in 50 μL B‐PER (Thermo Scientific) for lysis. After 30 min of incubation at room temperature, 30 μL was treated with SDS‐PAGE cracking buffer (20 mM Tris/HCl pH 6.8, 5 mM EDTA, 0.5% SDS, 0.1% β‐mercaptoethanol). The samples were centrifuged for 3 min. The soluble and lysate fraction samples were analyzed by running on a 4%–15% Mini‐PROTEIN TGX Stain Free Protein SDS‐PA gel. The signal intensity of the band corresponding to BlaC for each mutant was compared to the signal intensity of WT BlaC using ImageLab software (BioRad). The experiment was performed in triplicate.
5.5. Thermal stability
The thermal stability of BlaC mutants was determined by tryptophan fluorescence changes as a function of temperature using a Tycho NT.6 (NanoTemper Technologies, München, Germany). The fluorescence ratio at 330 and 350 nm was used to determine the melting temperature. All measurements were done in triplicate in 100 mM sodium phosphate buffer at pH 6.5.
5.6. Enzyme kinetics
Kinetic parameters on BlaC mutants were determined by monitoring the absorption change at 486 nm for nitrocefin hydrolysis (Δε486 = 18/mM/cm) (van Alen et al., 2023) with a TECAN infinite® M1000PRO plate reader at 25°C for 5 min. The initial velocities were fitted to the Michaelis–Menten equation:
| (1) |
where is the initial velocity, k cat is the turnover number, K M is the apparent Michaelis constant, [S] is the initial concentration of nitrocefin (0, 10, 20, 50, 100, 200, 300, and 400 μM) and [E] the concentration of BlaC (200 nM). The nitrocefin hydrolysis by WT BlaC (2 nM) was measured on a PerkinElmer Lambda 1050+ UV–Vis spectrometer at 25°C. The hydrolysis reaction comprises several steps, so the definition of K M differs from the standard one and is thus considered an apparent K M. To study ceftazidime hydrolysis, absorbance change at 260 nm (Δε260 = 7 ± 1 mM−1 cm−1) was measured for 5 min using 1 μM of BlaC and 35 μM ceftazidime at 10, 15, 20, 25, 30, or 35°C on a temperature‐controlled PerkinElmer Lambda 1050+ UV–Vis spectrometer. All kinetic measurements were performed in duplicate in 100 mM NaPi buffer (pH 6.5).
5.7. NMR spectroscopy
Standard HNCA and TROSY‐HSQC experiments were recorded using [15N, 13C] labeled BlaC mutants on a Bruker AVIII HD 850 MHz spectrometer with a TCI cryoprobe at 25°C in 100 mM sodium phosphate buffer (pH 6.5), with 1 mM TSP (trimethylsilylpropanoic acid) and 6% D2O in a Shigemi tube. Data were processed with Topspin 4.1.1 (Bruker Biospin) and analyzed using CcpNmr version 2 (Vranken et al., 2005). Assignments were based on those for the WT spectra at pH 6.5 (BMRB ID: 27067) (Elings et al., 2017), BlaC P167S spectra at pH 6.5 (BMRB ID: 51876) (Sun et al., 2023), and confirmed with HNCA spectra. The assignments for BlaC PD, PDD, PDDS, PDDSH, PDI, PDIH, PDTT, PDTTI, and PDTTID have been deposited in the BMRB under access codes 52517, 52518, 52679, 52680, 52631, 52686, 52683, 52684, and 52685, respectively. The average chemical shift differences between the two states observed for BlaC of the 1H () and 15N resonances of backbone amides were calculated with Equation (2).
| (2) |
5.8. Protein crystallization
Crystallization conditions for BlaC PD, PDDS, and PDDSH (12 mg mL−1) were screened by the sitting‐drop method using the JCSG+, BSC, PACT, and Morpheus screens (Molecular Dimensions, Catcliffe, UK) at 20°C with 200 nL drops with a 1:1 protein to screening condition ratio. Crystals of PD grew in 0.1 M sodium cacodylate at pH 6.07 with 1.16 M trisodium citrate as precipitant. A crystal of PDDS grew within 2 weeks in 0.1 M Bis‐Tris buffer, pH 5.5, and 2 M (NH4)2SO4 as additive. Crystals of PDDSH grew in 0.1 M MES buffer, pH 6.3, and with 0.864 M trisodium citrate as additive. After 1 month, the crystals were mounted on cryoloops in mother liquor, with the addition of 30% glycerol and flash frozen in liquid nitrogen for x‐ray data collection.
5.9. Data collection, processing, and structure refinement
Diffraction data for PD were collected at the Diamond Light Source (DLS, Oxford, England, Project MX25413). The PDDS and PDDSH structures were collected at the European Synchrotron Radiation Facility on the MASSIF beamline (Project MX2526). The resolution cutoff was determined based on completeness and CC1/2 values. The data were processed by XDS (Kabsch, 2010) and scaled using Aimless (Evans, 2011). The structures were solved by molecular replacement using MOLREP (Winn et al., 2011) from the CCP4 suite (Winn et al., 2011) with PDB entry 2GDN (Wang et al., 2006) as model for molecular replacement. Model building and refinement were performed in Coot and REFMAC (Winn et al., 2011). Waters were added in REFMAC during refinement. The models were further optimized using the PDB‐REDO web server (Joosten et al., 2014). The refinement and data collection statistics are given in Table S3. The structures for BlaC PD, PDDS, and PDDSH have been deposited in the Protein Data Bank (PDB ID: 9HIT, 9HCK, and 9HJ2).
AUTHOR CONTRIBUTIONS
Jing Sun: Conceptualization; methodology; data curation; investigation; validation; formal analysis; funding acquisition; visualization; writing – original draft; writing – review and editing. Monika Timmer: Methodology; investigation. Steffen Brünle: Formal analysis; validation; writing – review and editing. Aimee L. Boyle: Writing – review and editing. Marcellus Ubbink: Conceptualization; formal analysis; supervision; resources; project administration; visualization; funding acquisition; writing – original draft; writing – review and editing; methodology.
Supporting information
Data S1. Supporting Information.
ACKNOWLEDGMENTS
J.S. acknowledges support from the Chinese Scholarship Council (CSC grant, No. 201904910678). We thank Mr. P. Voskamp for technical support for the collection of the crystallography data and Dr. K.B. Sai Sankar Gupta for his assistance with NMR experiments. Furthermore, the authors acknowledge the European Synchrotron Radiation Facility (ESRF) Project MX2526 and the Diamond Light Source (DLS), Oxford, England for the provision of synchrotron radiation facilities (Project MX25413).
Sun J, Timmer M, Brünle S, Boyle AL, Ubbink M. Directed evolution of a beta‐lactamase samples a wide variety of conformational states. Protein Science. 2025;34(11):e70322. 10.1002/pro.70322
Review Editor: Aitziber L. Cortajarena
DATA AVAILABILITY STATEMENT
The data that support the findings of this study are available from the corresponding author upon reasonable request.
REFERENCES
- Alsenani T, Viviani S, Kumar V, Taracila M, Bethel C, Barnes M, et al. Structural characterization of the D179N and D179Y variants of KPC‐2 β‐lactamase: Ω‐loop destabilization as a mechanism of resistance to ceftazidime‐avibactam. Antimicrob Agents Chemother. 2022;66:e0241421. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ambler RP, Coulson AF, Frère J‐M, Ghuysen J‐M, Joris B, Forsman M, et al. A standard numbering scheme for the class A beta‐lactamases. Biochem J. 1991;276:269. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bae IK, Lee BH, Hwang HY, Jeong SH, Hong SG, Chang CL, et al. A novel ceftazidime‐hydrolysing extended‐spectrum β‐lactamase, CTX‐M‐54, with a single amino acid substitution at position 167 in the omega loop. J Antimicrob Chemother. 2006;58:315–319. [DOI] [PubMed] [Google Scholar]
- Berezovsky IN, Shakhnovich EI. Physics and evolution of thermophilic adaptation. Proc Natl Acad Sci. 2005;102:12742–12747. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bhabha G, Ekiert DC, Jennewein M, Zmasek CM, Tuttle LM, Kroon G, et al. Divergent evolution of protein conformational dynamics in dihydrofolate reductase. Nat Struct Mol Biol. 2013;20:1243–1249. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bloom JD, Arnold FH. In the light of directed evolution: pathways of adaptive protein evolution. Proc Natl Acad Sci. 2009;106:9995–10000. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Brown CA, Hu L, Sun Z, Patel MP, Singh S, Porter JR, et al. Antagonism between substitutions in β‐lactamase explains a path not taken in the evolution of bacterial drug resistance. J Biol Chem. 2020;295:7376–7390. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Campbell EC, Correy GJ, Mabbitt PD, Buckle AM, Tokuriki N, Jackson CJ. Laboratory evolution of protein conformational dynamics. Curr Opin Struct Biol. 2018;50:49–57. [DOI] [PubMed] [Google Scholar]
- Campbell E, Kaltenbach M, Correy GJ, Carr PD, Porebski BT, Livingstone EK, et al. The role of protein dynamics in the evolution of new enzyme function. Nat Chem Biol. 2016;12:944–950. [DOI] [PubMed] [Google Scholar]
- Campitelli P, Modi T, Kumar S, Ozkan SB. The role of conformational dynamics and allostery in modulating protein evolution. Annu Rev Biophys. 2020;49:267–288. [DOI] [PubMed] [Google Scholar]
- Casadevall G, Duran C, Osuna S. AlphaFold2 and deep learning for elucidating enzyme conformational flexibility and its application for design. JACS Au. 2023;3:1554–1562. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Delmas J, Robin F, Carvalho F, Mongaret C, Bonnet R. Prediction of the evolution of ceftazidime resistance in extended‐spectrum β‐lactamase CTX‐M‐9. Antimicrob Agents Chemother. 2006;50:731–738. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Elings W, Tassoni R, van der Schoot SA, Luu W, Kynast JP, Dai L, et al. Phosphate promotes the recovery of Mycobacterium tuberculosis β‐lactamase from clavulanic acid inhibition. Biochemistry. 2017;56:6257–6267. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Evans PR. An introduction to data reduction: space‐group determination, scaling and intensity statistics. Acta Crystallogr D Biol Crystallogr. 2011;67:282–292. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fasan R, Chen MM, Crook NC, Arnold FH. Engineered alkane‐hydroxylating cytochrome P450BM3 exhibiting nativelike catalytic properties. Angew Chem Int Ed. 2007;46:8414–8418. [DOI] [PubMed] [Google Scholar]
- Fasan R, Meharenna YT, Snow CD, Poulos TL, Arnold FH. Evolutionary history of a specialized P450 propane monooxygenase. J Mol Biol. 2008;383:1069–1080. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Feiler C, Fisher AC, Boock JT, Marrichi MJ, Wright L, Schmidpeter PA, et al. Directed evolution of Mycobacterium tuberculosis β‐lactamase reveals gatekeeper residue that regulates antibiotic resistance and catalytic efficiency. PLoS One. 2013;8:e73123. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fisette O, Gagné S, Lagüe P. Molecular dynamics of class A β‐lactamases—effects of substrate binding. Biophys J. 2012;103:1790–1801. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fisher JF, Mobashery S. Three decades of the class A β‐lactamase acyl‐enzyme. Curr Protein Pept Sci. 2009;10:401–407. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fraser JS, Clarkson MW, Degnan SC, Erion R, Kern D, Alber T. Hidden alternative structures of proline isomerase essential for catalysis. Nature. 2009;462:669–673. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fröhlich C, Bunzel HA, Buda K, Mulholland AJ, van der Kamp MW, Johnsen PJ, et al. Epistasis arises from shifting the rate‐limiting step during enzyme evolution of a β‐lactamase. Nat Catal. 2024;7:499–509. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ghiglione B, Rodríguez MM, Curto L, Brunetti F, Dropa M, Bonomo RA, et al. Defining substrate specificity in the CTX‐M family: the role of Asp240 in ceftazidime hydrolysis. Antimicrob Agents Chemother. 2018;62:e00116‐18. 10.1128/aac.00116-00118 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gobeil SM, Clouthier CM, Park J, Gagné D, Berghuis AM, Doucet N, et al. Maintenance of native‐like protein dynamics may not be required for engineering functional proteins. Chem Biol. 2014;21:1330–1340. [DOI] [PubMed] [Google Scholar]
- González MM, Abriata LA, Tomatis PE, Vila AJ. Optimization of conformational dynamics in an epistatic evolutionary trajectory. Mol Biol Evol. 2016;33:1768–1776. [DOI] [PMC free article] [PubMed] [Google Scholar]
- He Y, Lei J, Pan X, Huang X, Zhao Y. The hydrolytic water molecule of class A β‐lactamase relies on the acyl‐enzyme intermediate ES* for proper coordination and catalysis. Sci Rep. 2020;10:10205. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hobson CA, Pierrat G, Tenaillon O, Bonacorsi S, Bercot B, Jaouen E, et al. Klebsiella pneumoniae carbapenemase variants resistant to ceftazidime‐avibactam: an evolutionary overview. Antimicrob Agents Chemother. 2022;66:e0044722. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jackson CJ, Foo J‐L, Tokuriki N, Afriat L, Carr PD, Kim H‐K, et al. Conformational sampling, catalysis, and evolution of the bacterial phosphotriesterase. Proc Natl Acad Sci USA. 2009;106:21631–21636. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Joosten RP, Long F, Murshudov GN, Perrakis A. The PDB_REDO server for macromolecular structure model optimization. IUCrJ. 2014;1:213–220. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kabsch W. XDS. Acta Crystallogr D Biol Crystallogr. 2010;66:125–132. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kemp MT, Nichols DA, Zhang X, Defrees K, Na I, Renslo AR, et al. Mutation of the conserved Asp‐Asp pair impairs the structure, function, and inhibition of CTX‐M class A β‐lactamase. FEBS Lett. 2021;595:2981–2994. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Maria‐Solano MA, Serrano‐Hervás E, Romero‐Rivera A, Iglesias‐Fernández J, Osuna S. Role of conformational dynamics in the evolution of novel enzyme function. Chem Commun. 2018;54:6622–6634. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Martínez R, Schwaneberg U. A roadmap to directed enzyme evolution and screening systems for biotechnological applications. Biol Res. 2013;46:395–405. [DOI] [PubMed] [Google Scholar]
- Nearmnala P, Thanaburakorn M, Panbangred W, Chaiyen P, Hongdilokkul N. An in vivo selection system with tightly regulated gene expression enables directed evolution of highly efficient enzymes. Sci Rep. 2021;11(1):11669. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nijhuis R, Oueslati S, Zhou K, Bosboom R, Rossen J, Naas T. OXY‐2‐15, a novel variant showing increased ceftazidime hydrolytic activity. J Antimicrob Chemother. 2015;70:1429–1433. [DOI] [PubMed] [Google Scholar]
- Nirantar SR. Directed evolution methods for enzyme engineering. Molecules. 2021;26:5599. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Noda‐Garcia L, Tawfik DS. Enzyme evolution in natural products biosynthesis: target‐or diversity‐oriented? Curr Opin Chem Biol. 2020;59:147–154. [DOI] [PubMed] [Google Scholar]
- Novais A, Comas I, Baquero F, Canton R, Coque TM, Moya A, et al. Evolutionary trajectories of beta‐lactamase CTX‐M‐1 cluster enzymes: predicting antibiotic resistance. PLoS Pathog. 2010;6:e1000735. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Otten R, Liu L, Kenner LR, Clarkson MW, Mavor D, Tawfik DS, et al. Rescue of conformational dynamics in enzyme catalysis by directed evolution. Nat Commun. 2018;9:1314. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Otten R, Pádua RAP, Bunzel HA, Nguyen V, Pitsawong W, Patterson M, et al. How directed evolution reshapes the energy landscape in an enzyme to boost catalysis. Science. 2020;370:1442–1446. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Papp‐Wallace KM, Becka SA, Taracila MA, Zeiser ET, Gatta JA, LiPuma JJ, et al. Exploring the role of the Ω‐loop in the evolution of ceftazidime resistance in the PenA β‐lactamase from Burkholderia multivorans, an important cystic fibrosis pathogen. Antimicrob Agents Chemother. 2017;61:e01941‐01916. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Patel MP, Fryszczyn BG, Palzkill T. Characterization of the global stabilizing substitution A77V and its role in the evolution of CTX‐M β‐lactamases. Antimicrob Agents Chemother. 2015;59:6741–6748. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pemberton OA, Noor RE, Kumar MVV, Sanishvili R, Kemp MT, Kearns FL, et al. Mechanism of proton transfer in class A β‐lactamase catalysis and inhibition by avibactam. Proc Natl Acad Sci U S A. 2020;117:5818–5825. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Poirel L, Naas T, Le Thomas I, Karim A, Bingen E, Nordmann P. CTX‐M‐type extended‐spectrum β‐lactamase that hydrolyzes ceftazidime through a single amino acid substitution in the omega loop. Antimicrob Agents Chemother. 2001;45:3355–3361. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Radojković M, Ubbink M. Positive epistasis drives clavulanic acid resistance in double mutant libraries of BlaC β‐lactamase. Commun Biol. 2024;7:197. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Radojković M, van Ingen AB, Timmer M, Ubbink M. Stabilizing mutations enhance evolvability of BlaC β‐lactamase by widening the mutational landscape. J Mol Biol. 2025;437:168999. [DOI] [PubMed] [Google Scholar]
- Rossi M‐A, Palzkill T, Almeida FC, Vila AJ. Slow protein dynamics elicits new enzymatic functions by means of epistatic interactions. Mol Biol Evol. 2022;39:msac194. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Socha RD, Tokuriki N. Modulating protein stability‐directed evolution strategies for improved protein function. FEBS J. 2013;280:5582–5595. [DOI] [PubMed] [Google Scholar]
- Stimple SD, Smith MD, Tessier PM. Directed evolution methods for overcoming trade‐offs between protein activity and stability. AIChE J. 2020;66:e16814. [DOI] [PMC free article] [PubMed] [Google Scholar]
- St‐Jacques AD, Rodriguez JM, Eason MG, Foster SM, Khan ST, Damry AM, et al. Computational remodeling of an enzyme conformational landscape for altered substrate selectivity. Nat Commun. 2023;14:6058. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stojanoski V, Chow D‐C, Hu L, Sankaran B, Gilbert HF, Prasad BV, et al. A triple mutant in the Ω‐loop of TEM‐1 β‐lactamase changes the substrate profile via a large conformational change and an altered general base for catalysis. J Biol Chem. 2015;290:10382–10394. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Strynadka NC, Adachi H, Jensen SE, Johns K, Sielecki A, Betzel C, et al. Molecular structure of the acyl‐enzyme intermediate in β‐lactam hydrolysis at 1.7 Å resolution. Nature. 1992;359:700–705. [DOI] [PubMed] [Google Scholar]
- Sun J, Boyle AL, Brünle S, Ubbink M. A low‐barrier proton shared between two aspartates acts as a conformational switch that changes the substrate specificity of the β‐lactamase BlaC. Int J Biol Macromol. 2024;278:134665. [DOI] [PubMed] [Google Scholar]
- Sun J, Chikunova A, Boyle AL, Voskamp P, Timmer M, Ubbink M. Enhanced activity against a third‐generation cephalosporin by destabilization of the active site of a class A beta‐lactamase. Int J Biol Macromol. 2023;250:126160. [DOI] [PubMed] [Google Scholar]
- Tokuriki N, Stricher F, Schymkowitz J, Serrano L, Tawfik DS. The stability effects of protein mutations appear to be universally distributed. J Mol Biol. 2007;369:1318–1332. [DOI] [PubMed] [Google Scholar]
- Tokuriki N, Stricher F, Serrano L, Tawfik DS. How protein stability and new functions trade off. PLoS Comput Biol. 2008;4:e1000002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tokuriki N, Tawfik DS. Stability effects of mutations and protein evolvability. Curr Opin Struct Biol. 2009;19:596–604. [DOI] [PubMed] [Google Scholar]
- Tooke CL, Hinchliffe P, Beer M, Zinovjev K, Colenso CK, Schofield CJ, et al. Tautomer‐specific deacylation and Ω‐loop flexibility explain the carbapenem‐hydrolyzing broad‐spectrum activity of the KPC‐2 β‐lactamase. J Am Chem Soc. 2023;145:7166–7180. [DOI] [PMC free article] [PubMed] [Google Scholar]
- van Alen I, Chikunova A, van Zanten DB, de Block AA, Timmer M, Brünle S, et al. Asp179 in the class a β‐lactamase from mycobacterium tuberculosis is a conserved yet not essential residue due to epistasis. FEBS J. 2023;290:4933–4949. [DOI] [PubMed] [Google Scholar]
- Vidal LS, Isalan M, Heap JT, Ledesma‐Amaro R. A primer to directed evolution: current methodologies and future directions. RSC Chem Biol. 2023;4:271–291. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Vranken WF, Boucher W, Stevens TJ, Fogh RH, Pajon A, Llinas M, et al. The CCPN data model for NMR spectroscopy: development of a software pipeline. Proteins. 2005;59:687–696. [DOI] [PubMed] [Google Scholar]
- Wang F, Cassidy C, Sacchettini JC. Crystal structure and activity studies of the mycobacterium tuberculosis β‐lactamase reveal its critical role in resistance to β‐lactam antibiotics. Antimicrob Agents Chemother. 2006;50:2762–2771. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wayment‐Steele HK, Ojoawo A, Otten R, Apitz JM, Pitsawong W, Hömberger M, et al. Predicting multiple conformations via sequence clustering and AlphaFold2. Nature. 2024;625:832–839. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Winn MD, Ballard CC, Cowtan KD, Dodson EJ, Emsley P, Evans PR, et al. Overview of the CCP4 suite and current developments. Acta Crystallogr D Biol Crystallogr. 2011;67:235–242. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yi H, Cho K‐H, Cho YS, Kim K, Nierman WC, Kim HS. Twelve positions in a β‐lactamase that can expand its substrate spectrum with a single amino acid substitution. PLoS One. 2012;7:e37585. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yi H, Choi JM, Hwang J, Prati F, Cao T‐P, Lee SH, et al. High adaptability of the omega loop underlies the substrate‐spectrum‐extension evolution of a class A β‐lactamase, PenL. Sci Rep. 2016;6:36527. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data S1. Supporting Information.
Data Availability Statement
The data that support the findings of this study are available from the corresponding author upon reasonable request.
